Heart Center Mølholm Partners With CardioSignal to Enhance Patient Recovery with Easy-to-Use Heart Monitoring
Vejle, Denmark, October 2024 — CardioSignal announces an exciting new collaboration with Heart Center Mølholm, Mølholm Private Hospital, one of Denmark’s most esteemed private hospitals and pioneers in cutting-edge cardiac ablation. This partnership marks a significant step forward in improving post-procedure care for patients undergoing ablation treatment at Mølholm.
Mølholm now offers 12 months of complimentary access to the CardioSignal smartphone application to patients for detecting signs of atrial fibrillation at home after their ablation. Using the app is simple and seamless—patients only need to place their smartphone on their chest for one minute to measure their heart’s rhythm and see if there are signs of atrial fibrillation (AFib). No additional hardware is required, making it easy for patients to integrate heart health monitoring into their daily lives, wherever they are as they continue their recovery.
Heart Center Mølholm: Leading the Way in Patient-Centered Cardiac Care
Renowned for its patient-first approach, Heart Center Mølholm has consistently been a leader in delivering top-tier cardiac care, with particular expertise in the treatment of AFib. Mølholm's use of advanced ablation techniques, including state-of-the-art methods such as Pulsed Field Ablation (PFA), exemplifies their dedication to providing patients with the most effective and minimally invasive treatment options available.
This collaboration with CardioSignal is rooted in Mølholm’s core values of enhancing the quality of life for their patients. “Our goal is to reassure patients after their ablation by providing them with an easy-to-use solution that offers real-time heart monitoring without requiring additional hardware—just their smartphone,” said Dr. Peter Steen Hansen, chief cardiologist at Mølholm. “We also see this as an opportunity to facilitate early diagnosis of atrial fibrillation relapse and to optimize the entire ablation journey, improving both patient outcomes and overall care.”
Empowering Patients with Technology for Better Outcomes
This collaboration with CardioSignal allows Mølholm’s patients to take control of their heart health with confidence. The CardioSignal app is powered by advanced gyrocardiography technology, which detects subtle movements caused by the heart using a smartphone’s built-in movement sensors. With over 95% accuracy in detecting signs of AFib, the app provides real-time insights without the need for additional hardware.
Patients are empowered to monitor their heart rhythms from the comfort of their homes, reducing the need for frequent hospital visits and adding an extra layer of safety during their recovery. Speaking on the collaboration, Dr. Hansen added, “At Mølholm, we strive to go beyond just delivering the best treatment—we focus on continuous care that ensures our patients feel safe and well-supported, even after they leave the clinic. By integrating digital health solutions like CardioSignal into our post-ablation care, we’re helping our patients to manage their recovery more confidently.”
A New Standard in Post-Ablation Care
By combining Mølholm’s expertise in ablation procedures with CardioSignal’s advanced heart monitoring technology, this partnership sets a new standard in patient care. Together, we are ensuring that patients not only receive the best treatment during their time at the clinic but also the best recovery with ease and safety at home.
For more information on this collaboration, please visit CardioSignal and Heart Center Mølholm.
Media Contact:
CardioSignal
Lasse Leppäkorpi
Operations Executive
lasse.leppakorpi@cardiosignal.com
Heart Center Mølholm
Dr. Peter Steen Hansen
Chief Cardiologist
psh@molholm.dk